Company says affected lots will no longer be distributed
What appears to have been a very professional burglary of a Lilly warehouse in Enfield, CT, on March 14 sets a recent record for the size of the heist, reported to be $75 million. (Ironically, Lilly also suffered the next-highest recent robbery, of a $37-million truckload last May that was quickly recovered). Brandnames involved in the theft include Cymbalta, Prozac, Strattera, Symbyax, Zyprexa, Gemzar and Alimta. The latter two are oncology drugs; the others are psychoactive drugs for depression and other disorders, but are not known as commonly used by drug abusers.
According to press accounts and sources close to the investigation, an (assumed) crew chose a Saturday night (the DC is closed over the weekend), cut a hole in the roof, rappelled inside, disarmed the security system, and then loaded some 70 pallets of Lilly products into a vehicle or vehicles and made their getaway. This was not an opportunistic grab of an unattended trailer on a highway rest stop, or a stickup of a pharmacy delivery, two of the most common types of drug theft.
A Lilly statement issued on March 17 stated that the company is not withdrawing shipments of these lots made before March 14 (which went throughout the US, Puerto Rico and US territories), but will cease further distribution of the specific lots. What’s not clear in that statement is whether the affected lots will be a total writeoff; if so, the financial consequences of the burglary could be considerably higher. Moreover, Lilly is telling pharmacists and patients to examine prescription packages closely, looking for signs of tampering. (Most of the affected products are packaged in 30-count bottles, or as vials.)
Pharmaceutical Commerce recently reported that there are troubling trends indicating that organized crime, or at least organized criminals, are targeting pharmaceutical shipments. Trucks that leave known pharma warehouses are followed, sometimes for hundreds of miles. Stolen trailers or cases of products often quickly melt away. A Novo Nordisk robbery about a year ago resulted in multiple FDA warnings when stolen insulin showed up in a Houston medical center. And while Lilly noted in its statement that “the U.S. pharmaceutical distribution system is tightly controlled and monitored, making it extremely difficult for stolen product to make it to patients through legitimate channels,” there are numerous illegitimate channels, including unlicensed Internet pharmacies.
"The Lilly break was the largest burglary of its kind within recent memory," says Chuck Forsaith, director of security at Purdue Pharma and head of an industry group, the Pharmaceutical Cargo Security Coalition. "As bad as it was we will ultimately learn from it and strengthen the physical security of all of our assets to guard against any future attempts at this type of criminal activity."
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.